RecruitingNCT05436418
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
PHASE1 · PHASE2 · 260 planned enrolment
- Countries listed
- 1
- Registry update
- September 11, 2026
